Dow Down 0.71% Nasdaq Down 0.66%

PDL BioPharma, Inc. (PDLI)

-NasdaqGS
7.54 Up 0.07(0.87%) 11:06AM EDT - Nasdaq Real Time Price
Prev Close:7.47
Open:7.48
Bid:7.46 x 3300
Ask:7.47 x 1600
1y Target Est:7.67
Beta:0.51
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:7.40 - 7.54
52wk Range:7.38 - 10.26
Volume:656,467
Avg Vol (3m):2,945,640
Market Cap:1.21B
P/E (ttm):4.56
EPS (ttm):1.65
Div & Yield:0.60 (6.60%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PDLI

Comparison

Symbol% ChgMkt Cap
PDLIUp 0.87%1.21B
AMGNDown 0.27%106.41B
SGENDown 0.94%4.55B
XOMADown 1.82%442.59M

Key Statistics

Forward P/E (1 yr):3.09
P/S (ttm):2.73
Ex-Dividend Date:03-Dec-14

Analysts

Annual EPS Est (Dec-14) :2.20
Quarterly EPS Est (Sep-14) :0.61
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):0.25

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

PDL BioPharma, Inc. manages a portfolio of patents and royalty assets. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback